Ministerio da Saude - Instituto Nacional do Cancer
Rio De Janeiro, Brazil
Hospital no Rio de Janeiro
About Ministerio da Saude - Instituto Nacional do Cancer
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Ministerio da Saude - Instituto Nacional do Cancer
During the past decade, Ministerio da Saude - Instituto Nacional do Cancer conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
2009-09-01
2025-10-01
Active, not recruiting
1,538
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ministerio da Saude - Instituto Nacional do Cancer"
#1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Ministerio da Saude - Instituto Nacional do Cancer
According to Clinical.Site data, the most researched conditions in "Ministerio da Saude - Instituto Nacional do Cancer" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Multiple Myeloma" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Chronic Graft Versus Host Disease" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Ministerio da Saude - Instituto Nacional do Cancer" in a lesser frequency.
Clinical Trials Intervention Types at Ministerio da Saude - Instituto Nacional do Cancer
Most popular intervention types in "Ministerio da Saude - Instituto Nacional do Cancer" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Prednisone" (3 trials), "Amivantamab" (2 trials), "Niraparib" (2 trials), "Placebo" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ministerio da Saude - Instituto Nacional do Cancer
The vast majority of trials in "Ministerio da Saude - Instituto Nacional do Cancer" are
7 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Ministerio da Saude - Instituto Nacional do Cancer
Currently, there are NaN active trials in "Ministerio da Saude - Instituto Nacional do Cancer".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were undefined completed trials in Ministerio da Saude - Instituto Nacional do Cancer,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ministerio da Saude - Instituto Nacional do Cancer, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".